Articles dans des revues avec comité de lecture (127)
46.
Marquette, S., Amighi, K., Goole, J., Peerboom, C., Yates, A., Denis, L., & Langer, I. (2014). Stability study of full-length antibody (anti-TNF alpha) loaded PLGA microspheres. International journal of pharmaceutics, 470(1-2), 41-50. doi:10.1016/j.ijpharm.2014.04.06348.
Duret, C., Merlos, R., Wauthoz, N., Sebti, T., Vanderbist, F., & Amighi, K. (2014). Pharmacokinetic evaluation in mice of amorphous itraconazole-based dry powder formulations for inhalation with high bioavailability and extended lung retention. European journal of pharmaceutics and biopharmaceutics, 86(1), 46-54. doi:10.1016/j.ejpb.2013.03.00549.
Marquette, S., Peerboom, C., Yates, A., Denis, L., Goole, J., & Amighi, K. (2013). Encapsulation of immunoglobulin G by solid-in-oil-in-water: Effect of process parameters on microsphere properties. European journal of pharmaceutics and biopharmaceutics. doi:10.1016/j.ejpb.2013.10.01350.
Pilcer, G., De Bueger, V., Traina, K., Traore, H., Sebti, T., Vanderbist, F., & Amighi, K. (2013). Carrier-free combination for dry powder inhalation of antibiotics in the treatment of lung infections in cystic fibrosis. International journal of pharmaceutics, 451(1-2), 112-120. doi:10.1016/j.ijpharm.2013.04.06951.
Reeff, J., Gaignaux, A., Goole, J., Siepmann, J., Siepmann, F., Jérôme, C., Thomassin, J. M., De Vriese, C., & Amighi, K. (2013). Characterization and optimization of GMO-based gels with long term release for intraarticular administration. International journal of pharmaceutics, 451(1-2), 95-103. doi:10.1016/j.ijpharm.2013.04.07953.
Pilcer, G., Rosiere, R., Traina, K., Sebti, T., Vanderbist, F., & Amighi, K. (2013). New co-spray-dried tobramycin nanoparticles-clarithromycin inhaled powder systems for lung infection therapy in cystic fibrosis patients. Journal of pharmaceutical sciences, 102(6), DOI 10.1002/jps.23525 ABSTRACT:, 1836-46. doi:10.1002/jps.2352555.
Mathieu, V., Wauthoz, N., Lefranc, F., Niemann, H., Amighi, K., Kiss, R., & Proksch, P. (2013). Cyclic versus Hemi-Bastadins. Pleiotropic Anti-Cancer Effects: from Apoptosis to Anti-Angiogenic and Anti-Migratory Effects. Molecules, 18(3), 3543-3561. doi:10.3390/molecules1803354356.
Lallemand, B., Ouedraogo, M., Wauthoz, N., Lamkami, T., Mathieu, V., Jabin, I., Amighi, K., Kiss, R., Dubois, J., & Goole, J. (2013). Synthesis and plasma pharmacokinetics in CD-1 mice of a 18β-glycyrrhetinic acid derivative displaying anti-cancer activity. Journal of Pharmacy and Pharmacology, 65(3), 402-410. doi:10.1111/j.2042-7158.2012.01603.x57.
Van Woensel, M., Wauthoz, N., Rosiere, R., Amighi, K., Mathieu, V., Lefranc, F., Van Gool, S. W., & De Vleeschouwer, S. (2013). Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM? Cancers (Basel), 5(3), 1020-1048. doi:10.3390/cancers5031020